CARE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Carter Bankshares Inc (CARE) is not a strong buy for a beginner, long-term investor at this time. While the company has shown revenue growth, the decline in net income and lack of significant positive catalysts make it less compelling. Additionally, no strong trading signals or influential figures' activity supports immediate action.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. MACD is positive but contracting, and RSI is neutral at 63.901. Key support and resistance levels are Pivot: 23.981, R1: 24.689, S1: 23.272, R2: 25.127, S2: 22.834.
Revenue increased by 14.91% YoY in Q3 2025, indicating growth in the company's top line.
Net income dropped by 3.95% YoY, and there is no recent news or significant insider or hedge fund activity. Additionally, no recent congress trading data or influential figures' actions are available.
In Q3 2025, revenue increased to $36.76 million (+14.91% YoY), but net income dropped to $5.35 million (-3.95% YoY). EPS remained flat at 0.24.
No analyst rating or price target data available for evaluation.
